Abbott Gets FDA Clearance to Develop New Test for Measuring Vitamin D Levels

November 30, 2011

In vitro diagnostics firm Abbott (Abbott Park, IL) says it has received FDA clearance to develop a fully automated test for measuring vitamin D levels in patients.

In vitro diagnostics firm Abbott (Abbott Park, IL) says it has received FDA clearance to develop a fully automated test for measuring vitamin D levels in patients. The test measures 25-hydroxyvitamin D (25-OH vitamin D) and uses the company’s ARCHITECT laboratory testing platform.

“The new ARCHITECT 25-OH vitamin D assay has shown excellent precision and offers a fully automated solution that may help laboratories cope with escalating demand for vitamin D testing and help get results to physicians and their patients much sooner,” stated Brian Blaser, senior vice president, diagnostics, Abbott, in a press release.

The company says that with a simple blood test, the ARCHITECT 25-OH vitamin D assay can measure 25-OH vitamin D, the stable and easily measured form of vitamin D, which converts into the active form of the vitamin in the body and helps regulate calcium and phosphate levels.

Related Content:

Vitamins & Minerals